Advertisement
Canada markets open in 47 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7298
    +0.0000 (+0.00%)
     

  • CRUDE OIL

    83.23
    +0.42 (+0.51%)
     

  • Bitcoin CAD

    87,518.94
    -3,761.30 (-4.12%)
     

  • CMC Crypto 200

    1,361.17
    -21.40 (-1.55%)
     

  • GOLD FUTURES

    2,338.30
    -0.10 (-0.00%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6600
    +0.0080 (+0.17%)
     

  • NASDAQ futures

    17,401.50
    -263.00 (-1.49%)
     

  • VOLATILITY

    16.33
    +0.36 (+2.25%)
     

  • FTSE

    8,099.66
    +59.28 (+0.74%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6821
    +0.0002 (+0.03%)
     
MARKETS LIVE BLOG:

STOCK FUTURES SLIDE AFTER META'S REALITY CHECK, WITH GDP ON DECK

Owner of Facebook and Instagram plans to spend up to US$10B on AI infrastructure investments

Kaskela Law LLC Announces Shareholder Investigation of Eidos Therapeutics, Inc. - EIDX

ACCESSWIRE

PHILADELPHIA, PA / ACCESSWIRE / August 14, 2019 / Kaskela Law LLC announces that it is investigating Eidos Therapeutics, Inc. (“Eidos” or the “Company”) (EIDX) on behalf of the Company’s shareholders.

The investigation seeks to determine whether Eidos’ executive officers and directors violated the securities laws and/or breached their fiduciary duties, and whether shareholders have been harmed as a result of such actions.

Eidos shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585 or (888) 715 - 1740, or by email at skaskela@kaskelalaw.com, to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/eidos-thera/.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

ADVERTISEMENT

CONTACT:

D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
www.kaskelalaw.com
skaskela@kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

SOURCE: Kaskela Law LLC



View source version on accesswire.com:
https://www.accesswire.com/555930/Kaskela-Law-LLC-Announces-Shareholder-Investigation-of-Eidos-Therapeutics-Inc--EIDX